Las Vegas ?? New options for the treatment of actinic keratoses (AKs) allow dermatologists to tailor therapy according to patient needs and the lesion characteristics, said Roger I. Ceilley, M.D., at the Fall Clinical Dermatology Conference.
The Weekly Roundup: September 23-27
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
LEO Pharma Presents Extensive Data at EADV
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Positive Results Reported in Roflumilast 0.15% for AD Across Diverse Populations
Post Hoc Analysis of Vilobelimab in Hidradenitis Suppurativa Suggests Clinically Meaningful Benefits